Company

Obalon Therapeutics, Inc.

Obalon Therapeutics develops medical devices for weight management, including its Obalon Balloon System.

About

Obalon Therapeutics is based in Carlsbad, US, and develops non-surgical weight loss devices. Its Obalon Balloon System is a swallowable, gas-filled balloon for adults with a BMI of 30 to 40 kg/m², used with a diet and exercise plan. The company raised USD 75 mn in its IPO on October 5, 2016, selling 5 million shares at USD 15 per share.

8Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in